Compared with sporadic breast cancer, patients with germline BRCA PVs are more likely to develop contralateral breast cancer, the cumulative risk 20 years after breast cancer diagnosis was 40% for BRCA1 and 26% for BRCA2 (17). Here, BRCA1 is linked to breast carcinoma.